Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | L3MBTL1 | Q9Y468 | 2/20 | 0.38 |
| ▸ | NPC1 | O15118 | 2/20 | 0.38 |
| ▸ | RAB9A | P51151 | 2/20 | 0.38 |
| ▸ | PKM | P14618 | 1/20 | 0.38 |
| ▸ | ATM | Q13315 | 1/20 | 0.38 |
| ▸ | GSK3B | P49841 | 1/20 | 0.38 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.35 |
| ▸ | CYP2A6 | P11509 | 4/20 | 0.34 |
| ▸ | POLB | P06746 | 2/20 | 0.34 |
| ▸ | NISCH | Q9Y2I1 | 1/20 | 0.34 |
| ▸ | GAA | P10253 | 3/20 | 0.33 |
| ▸ | HPGD | P15428 | 3/20 | 0.33 |
| ▸ | HSD17B10 | Q99714 | 2/20 | 0.33 |
| ▸ | ALOX5 | P09917 | 2/20 | 0.33 |
| ▸ | HTT | P42858 | 2/20 | 0.33 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.33 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.33 |
| ▸ | MEN1 | O00255 | 1/20 | 0.33 |
| ▸ | USP2 | O75604 | 1/20 | 0.33 |
| ▸ | LMNA | P02545 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL113923 | 0.89 | — | — | |
| SCHEMBL10584362 | 0.75 | NPC1 (0.35) | L3MBTL1NPC1RAB9APKMATM | |
| SCHEMBL20183982 | 0.75 | ALDH1A1 (0.42) | L3MBTL1NPC1RAB9APKMATM | |
| Formamide SCHEMBL11400245 | 0.75 | NPC1 (0.40) | L3MBTL1NPC1RAB9APKMATM | |
| Glycolic Acid SCHEMBL11539039 | 0.75 | GSK3B (0.44) | NPC1RAB9APKMGSK3BALDH1A1 | |
| SCHEMBL752807 | 0.68 | ACHE (0.45) | L3MBTL1NPC1RAB9APKMALDH1A1 | |
| SCHEMBL2961814 | 0.67 | — | — | |
| SCHEMBL2975411 | 0.67 | — | — | |
| SCHEMBL43816 | 0.67 | — | — | |
| SCHEMBL764849 | 0.67 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 193 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-8921299-B2 | Detergents having acceptable color | THE PROCTER & GAMBLE COMPANY (US) | 2014-12-30 | — | — | US | claimed |
| US-20260110139-A1 | CROSS-LINKED POLYVINYL ALCOHOL ADHESIVES | PROCTER & GAMBLE (US) | 2026-04-23 | — | — | US | disclosed |
| US-20260109131-A1 | CROSS-LINKED POLYVINYL ALCOHOL ADHESIVES | PROCTER & GAMBLE (US) | 2026-04-23 | — | — | US | disclosed |
| US-12522813-B2 | Mannanase for formulations having pH 5-12 | BASF SE (DE) | 2026-01-13 | — | — | US | disclosed |
| EP-4638687-A2 | DETERGENT COMPOSITION COMPRISING CATALASE AND AMYLASE | Novozymes A/S (DK) | 2025-10-29 | — | — | EP | disclosed |
| EP-4634219-A1 | HIGH STRENGTH LIQUID PROTEASE FORMULATIONS | Novozymes A/S (DK) | 2025-10-22 | — | — | EP | disclosed |
| US-20250295120-A1 | CLEANING METHOD, USE OF ENZYMES AND CLEANING COMPOSITION | NOVOZYMES A/S (DK) | 2025-09-25 | — | — | US | disclosed |
| US-20250129307-A1 | Microencapsulation Using Amino Sugar Oligomers | NOVOZYMES A/S (DK) | 2025-04-24 | — | — | US | disclosed |
| US-20250084346-A1 | ENCAPSULATED SOLID ENZYME PRODUCT | NOVOZYMES A/S (DK) | 2025-03-13 | — | — | US | disclosed |
| EP-4466364-A1 | CLEANING METHOD, USE OF ENZYMES AND CLEANING COMPOSITION | Novozymes A/S (DK) | 2024-11-27 | — | — | EP | disclosed |
| US-20110005003-A1 | CATALYTIC LAUNDRY DETERGENT COMPOSITION COMPRISING RELATIVELY LOW LEVELS OF WATER-SOLUBLE ELECTROLYTE | THE PROCTER & GAMBLE COMPANY (US) | 2011-01-13 | — | — | US | disclosed |
| EP-2252682-A1 | CLEANING COMPOSITIONS | The Procter & Gamble Company (US) | 2010-11-24 | — | — | EP | disclosed |
| US-20100120649-A1 | Stable Enzyme Solutions and Method of Manufacturing | NOVOZYMES A/S (DK) | 2010-05-13 | — | — | US | disclosed |
| EP-2139979-A1 | STABLE ENZYME SOLUTIONS AND METHOD OF MANUFACTURING | Novozymes A/S (DK) | 2010-01-06 | — | — | EP | disclosed |
| US-20090209447-A1 | CLEANING COMPOSITIONS | THE PROCTER & GAMBLE COMPANY | 2009-08-20 | — | — | US | disclosed |
| WO-2009102854-A1 | CLEANING COMPOSITIONS | THE PROCTER & GAMBLE COMPANY (US) | 2009-08-20 | — | — | WO | disclosed |
| WO-2008116915-A1 | STABLE ENZYME SOLUTIONS AND METHOD OF MANUFACTURING | NOVOZYMES A/S (DK) | 2008-10-02 | — | — | WO | disclosed |
| EP-1924677-A1 | STABILIZATION OF CONCENTRATED LIQUID ENZYME ADDITIVES | Novozymes A/S (DK) | 2008-05-28 | — | — | EP | disclosed |
| US-20070060493-A1 | Stabilization of concentrated liquid enzyme additives | NOVOZYMES A/S (DK) | 2007-03-15 | — | — | US | disclosed |
| WO-2007025549-A1 | STABILIZATION OF CONCENTRATED LIQUID ENZYME ADDITIVES | NOVOZYMES A/S (DK) | 2007-03-08 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20250295120-A1 | CLEANING METHOD, USE OF ENZYMES AND CLEANING COMPOSITION | DNASE1, HEXD, HEXA | L3MBTL1 4594/4885NPC1 3916/4885RAB9A 3773/4885 |
| US-20260109131-A1 | CROSS-LINKED POLYVINYL ALCOHOL ADHESIVES | VCAM1, PLOD3, TLN1 | L3MBTL1 1337/4885NPC1 3544/4885RAB9A 2914/4885 |
| US-20260110139-A1 | CROSS-LINKED POLYVINYL ALCOHOL ADHESIVES | VCL, PLOD3, ILK | L3MBTL1 1181/4885NPC1 3812/4885RAB9A 3954/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.